City

Condition

Metastatic Bone Disease (2)

Breast Cancer (1)

Solid Tumor (1)

Overall Status

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (1)

phase 4 (1)

Sponsor

Amgen (1)

Merck Sharp & Dohme LLC (1)

Collaborator

Intervention

denosumab (1)

odanacatib (1)

odanacatib matching placebo (1)

pamidronate (1)

za (1)

za matching placebo (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

metastatic bone disease

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Breast Cancer, Metastatic Bone Disease Trial (ZA, Odanacatib, Odanacatib matching )

Completed

Has Results

Breast Cancer
Metastatic Bone Disease

ZA
+3 more

(no location specified)

Jul 18, 2018

Solid Tumor, Metastatic Bone Disease Trial (denosumab, pamidronate)

Withdrawn

Solid Tumor
Metastatic Bone Disease

denosumab
pamidronate

(no location specified)

Feb 16, 2015